MAT
46
12
APD
59
2
VTR
47
-7
RHI
59
2
HSIC
56
5
GT
62
6
HOG
35
2
NTAP
67
-3
MTB
67
2
PBI
69
4
ADSK
70
2
LLY
37
-3
ILMN
42
5
PVH
62
5
JPM
69
2
DHI
48
4
LRCX
43
-2
IPG
56
3
CF
57
-2
TXT
55
3
MAT
46
12
APD
59
2
VTR
47
-7
RHI
59
2
HSIC
56
5
GT
62
6
HOG
35
2
NTAP
67
-3
MTB
67
2
PBI
69
4
ADSK
70
2
LLY
37
-3
ILMN
42
5
PVH
62
5
JPM
69
2
DHI
48
4
LRCX
43
-2
IPG
56
3
CF
57
-2
TXT
55
3
Financhill
Back

GlycoMimetics Vs. Arbutus Biopharma Industry Stock Comparison

Sell
47

GLYC
GlycoMimetics

Last Price:
0.32
Seasonality Move:
11.03%
Sell
37

ABUS
Arbutus Biopharma

Last Price:
3.51
Seasonality Move:
24.22%
Sell
47
GlycoMimetics (GLYC) is a Sell

Is GlycoMimetics a Buy, Sell or Hold?

  • The current GlycoMimetics [GLYC] share price is $0.32. The Score for GLYC is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • GLYC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Arbutus Biopharma (ABUS) is a Sell

Is Arbutus Biopharma a Buy, Sell or Hold?

  • The current Arbutus Biopharma [ABUS] share price is $3.51. The Score for ABUS is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • ABUS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GLYC Stock Price Chart

What is GlycoMimetics's stock price today?

  • The GlycoMimetics share price today is $0.32
    The current trend is moderately bearish and GLYC is experiencing slight selling pressure.

ABUS Stock Price Chart

What is Arbutus Biopharma's stock price today?

  • The Arbutus Biopharma share price today is $3.51
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing slight buying pressure.

GLYC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.03 Buy
Relative Strength Index (14 RSI): 47.47 Sell
Chaikin Money Flow: -460494 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.24 - 0.44) Sell
Bollinger Bands (100): (0.14 - 0.32) Buy

ABUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 34.97 Sell
Chaikin Money Flow: 429896 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.59 - 4.01) Sell
Bollinger Bands (100): (3.58 - 4.12) Sell

GLYC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.37 Sell
20-day SMA: 0.39 Sell
50-day SMA: 0.25 Buy
200-day SMA: 0.96 Sell
8-day EMA: 0.36 Sell
20-day EMA: 0.35 Sell
50-day EMA: 0.3 Buy
200-day EMA: 0.74 Sell

ABUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.54 Sell
20-day SMA: 3.74 Sell
50-day SMA: 3.89 Sell
200-day SMA: 3.38 Buy
8-day EMA: 3.55 Sell
20-day EMA: 3.69 Sell
50-day EMA: 3.8 Sell
200-day EMA: 3.43 Buy

GlycoMimetics Earnings Growth & GLYC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.01 per share.

Arbutus Biopharma Earnings Growth & ABUS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.

GlycoMimetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Arbutus Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):